Dr. William G. Tenbrink Jr., MD

Dr. Tenbrink practices at M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview.

Dr. Tenbrink's NPI, 1710419403, was assigned on March 31, 2017. Dr. Tenbrink graduated from Michigan State University College of Human Medicine in 2017. Dr. Tenbrink holds Minnesota license 66935.

Dr. Tenbrink's primary practice is M Health Fairview University of Minnesota Medical Center, at 2450 Riverside Avenue, Minneapolis, MN 55454 in Hennepin County. The practice phone is (612) 624-1765.

Dr. Tenbrink's primary practice is M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview. Dr. Tenbrink is also affiliated with Hennepin County Medical Center. The medical group on file is Fairview Health Services. Dmand AI also links Dr. Tenbrink to 5 more medical groups and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tenbrink practices, 3 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Tenbrink's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Tenbrink is licensed in Minnesota.

CMS data shows 425 Medicare services from Dr. Tenbrink across 5 procedure codes in 2024, for 245 Medicare patients. Medicare paid $31,478 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 245 Medicare patients who saw Dr. Tenbrink in 2024. The largest group is under 65, with 109 patients. 70% of them have high blood pressure, and 58% have high cholesterol. 49% are also on Medicaid. Their average risk score is 2.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tenbrink's median patient age at 55, with 54% women.

In 2024, Dr. Tenbrink wrote 187 Medicare Part D claims for 103 patients. 90% of them were for generic drugs. CMS names the drug for 80 of them, across 5 drugs with 11 or more claims each, at $594 in total drug cost. In 2023, CMS named 18 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Tenbrink for performance year 2024, reported as part of a group. Dr. Tenbrink accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Tenbrink. Dr. Tenbrink's most frequent co-authors are Glenn Michael Paetow, MD and Rochelle A. Zarzar, MD.

Dr. Tenbrink graduated from Michigan State University College of Human Medicine in 2017.